'Multicenter study' diaporamas de présentation

Candiduria: Should we treat, when and how?

Candiduria: Should we treat, when and how?. Hail M. Al-Abdely, MD Consultant Infectious Diseases King Faisal Specialist Hospital & Research Center. Presentation Outline. How common is this problem? Who gets it? Why do we get candiduria? Why should we treat it?

1.52k views • 59 slides

(AKI) Acute Kidney Injury

1.81k views • 49 slides

Multicenter Trials Industry-sponored Trials

Multicenter Trials Industry-sponored Trials. Steve Cummings, MD Director, SF Coordinating Center. Outline. Multicenter studies NIH-style studies Industry-sponsored studies Being a site in an industry study How to work with industry Publications Heresies. NIH-style studies.

716 views • 46 slides

Universal Immunization Against Rare Diseases

475 views • 33 slides

Anal Fissure What? When? Why?

1.02k views • 24 slides

UTILITY OF NMP22 BLADDERCHEK POINT-OF-CARE ASSAY IN EVALUATION OF HEMATURIA: A MULTICENTER STUDY

UTILITY OF NMP22 BLADDERCHEK POINT-OF-CARE ASSAY IN EVALUATION OF HEMATURIA: A MULTICENTER STUDY. Giora Katz* M.D. Lakeshore Urology manitowoc WI, and the NMP22 Clinical Investigation Group. Author Disclosure Matritech, Inc. : Honorarium. Introduction.

432 views • 19 slides

347 views • 19 slides

12-Week, Randomized, Multicenter Study Comparing Fixed-Combination Brimonidine-Timolol and Timolol as Adjunctive Th

12-Week, Randomized, Multicenter Study Comparing Fixed-Combination Brimonidine-Timolol and Timolol as Adjunctive Therapy to Latanoprost.

287 views • 12 slides

N ational C ouncil on F olic A cid

N ational C ouncil on F olic A cid. National Meeting June 29, 2009 Take Home Messages. The National Council on Folic Acid is managed by the Spina Bifida Association, 4590 MacArthur Blvd., NW, Suite 250 Washington, DC 20007-4226, 800-621-3141x13, www.folicacidinfo.org . .

290 views • 9 slides

Background

Cetuximab Plus Irinotecan for Metastatic Colorectal Cancer (mCRC): Safety Analysis of the first 800 Patients in a Randomized Phase III Trial (EPIC): Abstract #3556. Y.A. Abubakr, C. Eng, V. Pautret, J.Maurel, W. Scheithauer, H. Kroning, A. Zubel, M.P. Lutz, L. Wong, A. Sobrero. Background.

191 views • 8 slides